Under construction – not a live service

Skip to content

Frontlight Research

Researcher profile · from public sources

Navin Khattry

Tata Memorial Hospital, IndiaORCID 0000-0001-5708-64726 publications · 0 trials

This is me: claim the profile

Now

Trials, publications and grants since Nov 2024.

Publication
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.
JCO global oncology, Feb 2026
Publication
Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia.
Journal of translational medicine, Jan 2026
Publication
Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.
Blood cancer journal, Jan 2026
Publication
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India.
EJHaem, Dec 2025
Publication
Second Primary Malignancies Post Autologous Stem-cell Transplant in Multiple Myeloma from India - Knowing the Unknown.
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, Apr 2025

Affiliations

Tata Memorial Hospital

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.

Sources: OpenAlex · Updated 11 Dec 2025This is not me Correct something Object to this profile

Is this you? Request a correction or removal: support@frontlightresearch.com

Report an error

Under construction, not live – Navin Khattry: research profile – Frontlight Research